Awarded contractOpenSuppliesPoland
Postępowanie w trybie przetargu nieograniczonego na zakup leków w ramach programu lekowego - Aflibercept, Ranibizumab, Farcymab i Bewacyzumab
3 suppliers awarded•4 lots awarded•€368,313 awarded
Buyer: Szpital Miejski św. Jana Pawła II w Elblągu / Elbląg, Poland
Published Jul 16, 2024Awarded Apr 29, 2024
Pharmaceutical products
Awarded value
€368.3K
Estimated value
€368.3K
Awarded at 100% of estimated value
Award date
Apr 29, 2024
Winners
3
Lots awarded
4
Winners
Roche Polska Sp. z o.o
1 lotWarszawa, POL
€96,152 This contract
6 award notices•7 awarded lots•€379,938 total
Bialmed Sp. z o. o.
1 lotWarszawa, POL
€1,608 This contract
245 award notices•604 awarded lots•€18.61M total
1 lot
€542 This contract
107 award notices•385 awarded lots•€47.86M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0002 | Not specified | €270,011 | Pharmaceutical products (33600000) | |
| LOT-0003 | Roche Polska Sp. z o.o | €96,152 | Pharmaceutical products (33600000) | |
| LOT-0004 | Bialmed Sp. z o. o. | €1,608 | Pharmaceutical products (33600000) | |
| LOT-0001 | Baxter Polska Sp. z o.o., ul. Kruczkowskiego 8, 00-380 Warszawa | €542 | Pharmaceutical products (33600000) |